Industry: Plant-Based & Alternative Proteins (Food & Beverage)
Source: https://www.mordorintelligence.com/industry-reports/fava-bean-protein-market
Scraped Date: 2026-09-17
| Market Metric | Details |
|---|---|
| Base Market Size | USD 310.22 million |
| Projected Forecast (2031) | USD 310.22 million |
| Growth Rate (CAGR) | 9.20 % |
| Largest Market Region | N/A |
| Fastest-Growing Region | N/A |
!Major players in Fava Bean Protein industry
!Fava Bean Protein Market Size
!Fava Bean Protein Market Share by Product Type, 2024
!Fava Bean Protein Market Share by Application, 2024
!Fava Bean Protein Market CAGR (%), Growth Rate by Region
!Fava Bean Protein Market Concentration
!Icon
!Vijeron Intelligence on Facebook
!Vijeron Intelligence on Pinterest
!Vijeron Intelligence on Instagram
!GPTW
Market OverviewStudy Period | 2020 - 2030 |
Market Size (2025) | USD 310.22 Million |
Market Size (2030) | USD 481.70 Million |
Growth Rate (2025 - 2030) | 9.20 % |
Fastest Growing Market | Asia Pacific |
Largest Market | Europe |
Market Concentration | Medium |
Major Players*Disclaimer: Major Players sorted in no particular order
Image © Vijeron Intelligence. Reuse requires attribution under CC BY 4.0.
|
Fava Bean Protein Market Analysis by Vijeron IntelligenceThe fava bean protein market size stands at USD 310.22 million in 2025 and is projected to reach USD 481.7 million by 2030, reflecting a 9.2% CAGR and underscoring an accelerating global pivot toward sustainable, allergen-friendly plant proteins that can complement or replace soy and pea. Rising demand for clean-label formulations, a widening roster of sports-nutrition applications, and decisive regulatory clarity in both the United States and the European Union collectively fuel this expansion. Manufacturers are prioritizing dry-fractionation and hybrid extraction technologies that lower water and energy requirements, align with corporate net-zero targets, and improve cost structures[1]Center for Food Safety and Applied Nutrition, “Recently Published GRAS Notices and FDA Letters,” fda.gov. Europe benefits from the deepest installed processing base and favorable agri-policy support, yet Asia-Pacific delivers the highest incremental volume growth as Chinese pulse programs scale. North American players leverage a series of FDA GRAS notices to fast-track novel SKUs, while new capital projects in Germany and Canada provide proof points for scalable, zero-waste production.
Key Report Takeaways* By product type, isolates captured 46.84% of the fava bean protein market share in 2024, while textured protein is forecast to expand at a 9.27% CAGR through 2030.
Market Trends and InsightsDrivers Impact Analysis of Fava Bean Protein Market*Driver | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
Plant-based diet mainstreaming in US and EU retail channels | +1.8% | North America & EU | Medium term (2-4 years) |
Demand for allergen-friendly protein in sports-nutrition RTD beverages | +1.2% | Global | Short term (≤ 2 years) |
Regulatory tailwinds: GRAS clearance and EU novel-food self-determinations | +2.1% | North America & EU | Short term (≤ 2 years) |
Food-industry pivot to dry-fractionated proteins to cut water/energy use | +1.5% | Global | Medium term (2-4 years) |
Corporate net-zero targets driving pulse-based ingredient sourcing | +1.3% | Global | Long term (≥ 4 years) |
Rapid adoption of textured fava protein by global meat-analog manufacturers | +1.1% | Global | Short term (≤ 2 years) |
Source: Vijeron Intelligence |
Competitive Landscape
The fava bean protein market exhibits a moderate concentration, with the top five suppliers holding an estimated 60-70% combined share. Roquette leverages proprietary wet-extraction expertise and an extensive B2B distribution network to retain lead customer share in beverage and meat-analog sub-segments. BENEO follows with dry-fractionation technology that aligns with EU sustainability mandates and produces integrated starch and fiber co-products that improve plant economics. Ingredion differentiates through customized texturates and regional application labs that optimize formulations in local cuisines. Cosun Protein and Atura Proteins round out the top tier with specialized functional concentrates that target gluten-free bakery and snack-bar applications.
Emerging challengers focus on patented solid-state fermentation and enzymatic hydrolysis that unlock higher digestibility scores and bioactive peptide fractions. Burcon NutraScience’s 2025 launch of FavaPro demonstrates scale-up success in 90%-pure isolates using low-pH extraction systems, opening doors to medical-nutrition applications. Canadian and European farmer-cooperatives explore co-ownership models for new plants, aiming to capture more margin at the farm gate. Overall, technology innovation and geographic expansion into Asia-Pacific remain dominant strategic thrusts, underscoring an evolving yet opportunity-rich competitive landscape.
Fava Bean Protein Industry Leaders* Roquette
Image © Vijeron Intelligence. Reuse requires attribution under CC BY 4.0.
Global Fava Bean Protein Market Report ScopeBy Product TypeIsolate |
Concentrate |
Textured Protein |
By GeographyNorth America | United States |
| Canada |
|---|
| Mexico |
| Rest of North America |
Europe | Germany |
| United Kingdom |
|---|
| Italy |
| France |
| Spain |
| Netherlands |
| Poland |
| Belgium |
| Sweden |
| Rest of Europe |
Asia-Pacific | China |
| India |
|---|
| Japan |
| Australia |
| Indonesia |
| South Korea |
| Thailand |
| Singapore |
| Rest of Asia-Pacific |
South America | Brazil |
| Argentina |
|---|
| Colombia |
| Chile |
| Peru |
| Rest of South America |
Middle East and Africa | South Africa |
| Saudi Arabia |
|---|
| United Arab Emirates |
| Nigeria |
| Egypt |
| Morocco |
| Turkey |
| Rest of Middle East and Africa |
The fava bean protein market is valued at USD 310.22 million in 2025 and is projected to reach USD 481.7 million by 2030 at a 9.2% CAGR.
Europe holds the largest share at 32.59% on the back of extensive processing infrastructure and supportive policy frameworks.
Textured fava protein is expanding at 9.27% CAGR as meat-analog brands seek improved texture and neutral flavor.
FDA GRAS notices and streamlined EU novel-food procedures significantly shorten time to market and lower compliance costs.
A price premium over soy and pea, plus limited fractionation capacity outside Europe and Canada, remain chief constraints.